Heteropentanuclear Oxalato‐Bridged nd–4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis,Crystal Structures,Aqueous Stability and Antiproliferative Activity

A series of heteropentanuclear oxalate‐bridged Ru(NO)‐Ln (4d–4f) metal complexes of the general formula (nBu₄N)₅[Ln{RuCl₃(μ‐ox)(NO)}₄], where Ln=Y ( 2 ), Gd ( 3 ), Tb ( 4 ), Dy ( 5 ) and ox=oxalate anion, were obtained by treatment of (nBu₄N)₂[RuCl₃(ox)(NO)] ( 1 ) with the respective lanthanide salt in 4:1 molar ratio. The compounds were characterized by elemental analysis, IR spectroscopy, electrospray ionization (ESI) mass spectrometry, while 1 , 2 , and 5 were in addition analyzed by X‐ray crystallography, 1 by Ru K‐edge XAS and 1 and 2 by ¹³C NMR spectroscopy. X‐ray diffraction showed that in 2 and 5 four complex anions [RuCl₃(ox)(NO)]^2? are coordinated to Y^III and Dy^III, respectively, with formation of [Ln{RuCl₃(μ‐ox)(NO)}₄]^5? (Ln=Y, Dy). While Y^III is eight‐coordinate in 2 , Dy^III is nine‐coordinate in 5 , with an additional coordination of an EtOH molecule. The negative charge is counterbalanced by five nBu₄N⁺ ions present in the crystal structure. The stability of complexes 2 and 5 in aqueous medium was monitored by UV/Vis spectroscopy. The antiproliferative activity of ruthenium‐lanthanide complexes 2 – 5 were assayed in two human cancer cell lines (HeLa and A549) and in a noncancerous cell line (MRC‐5) and compared with those obtained for the previously reported Os(NO)‐Ln (5d–4f) analogues (nBu₄N)₅[Ln{OsCl₃(ox)(NO)}₄] (Ln=Y ( 6 ), Gd ( 7 ), Tb ( 8 ), Dy ( 9 )). Complexes 2 – 5 were found to be slightly more active than 1 in inhibiting the proliferation of HeLa and A549 cells, and significantly more cytotoxic than 5d–4f metal complexes 6 – 9 in terms of IC₅₀ values. The highest antiproliferative activity with IC₅₀ values of 20.0 and 22.4 μM was found for 4 in HeLa and A549 cell lines, respectively. These cytotoxicity results are in accord with the presented ICP‐MS data, indicating five‐ to eightfold greater accumulation of ruthenium versus osmium in human A549 cancer cells.     

Synthesis and Characterization of Multiferrocenyl‐Substituted Group 4 Metallocene Complexes

The reaction of different metallocene fragments [Cp₂M] (Cp=η⁵‐cyclopentadienyl, M=Ti, Zr) with diferrocenylacetylene and 1,4‐diferrocenylbuta‐1,3‐diyne is described. The titanocene complexes form the highly strained three‐ and five‐membered ring systems [Cp₂Ti(η²‐FcC₂Fc)] ( 1 ) and [Cp₂Ti(η⁴‐FcC₄Fc)] ( 2 ) (Fc=[Fe(η⁵‐C₅H₄)(η⁵‐C₅H₅)]) by addition of the appropriate alkyne or diyne to Cp₂Ti. Zirconocene precursors react with diferrocenyl‐ and ferrocenylphenylacetylene under C? C bond coupling to yield the metallacyclopentadienes [Cp₂Zr(C₄Fc₄)] ( 3 ) and [Cp₂Zr(C₄Fc₂Ph₂)] ( 5 ), respectively. The exchange of the zirconocene unit in 3 by hydrogen atoms opens the route to the super‐crowded ferrocenyl‐substituted compound tetraferrocenylbutadiene ( 4 ). On the other hand, the reaction of 1,4‐diferrocenylbuta‐1,3‐diyne with zirconocene complexes afforded a cleavage of the central C? C bond, and thus, dinuclear [{Cp₂Zr(μ‐η¹:η²‐C?CFc)}₂] ( 6 ) that consists of two zirconocene acetylide groups was formed. Most of the complexes were characterized by single‐crystal X‐ray crystallography, showing attractive multinuclear molecules. The redox properties of 3 , 5 , and 6 were studied by cyclic voltammetry. Upon oxidation to 3 ⁿ⁺, 5 ⁿ⁺, and 6 ⁿ⁺ (n=1–3), decomposition occured with in situ formation of new species. The follow‐up products from 3 and 5 possess two or four reversible redox events pointing to butadiene‐based molecules. However, the dinuclear complex 6 afforded ethynylferrocene under the measurement conditions.     

Study of the Bonding Modes of Di‐2‐pyridyl ketoxime Ligand towards Ruthenium,Rhodium and Iridium Half Sandwich Complexes

The bonding modes of the ligand di‐2‐pyridyl ketoxime towards half‐sandwich arene ruthenium, Cp*Rh and Cp*Ir complexes were investigated. Di‐2‐pyridyl ketoxime {pyC(py)NOH} react with metal precursor [Cp*IrCl₂]₂ to give cationic oxime complexes of the general formula [Cp*Ir{pyC(py)NOH}Cl]PF₆ ( 1a ) and [Cp*Ir{pyC(py)NOH}Cl]PF₆ ( 1b ), for which two coordination isomers were observed by NMR spectroscopy. The molecular structures of the complexes revealed that in the major isomer the oxime nitrogen and one of the pyridine nitrogen atoms are coordinated to the central iridium atom forming a five membered metallocycle, whereas in the minor isomer both the pyridine nitrogen atoms are coordinated to the iridium atom forming a six membered metallacyclic ring. Di‐2‐pyridyl ketoxime react with [(arene)MCl₂]₂ to form complexes bearing formula [(p‐cymene)Ru{pyC(py)NOH}Cl]PF₆ ( 2 ); [(benzene)Ru{pyC(py)NOH}Cl]PF₆ ( 3 ), and [Cp*Rh{pyC(py)NOH}Cl]PF₆ ( 4 ). In case of complex 3 the ligand coordinates to the metal by using oxime nitrogen and one of the pyridine nitrogen atoms, whereas in complex 4 both the pyridine nitrogen atoms are coordinated to the metal ion. The complexes were fully characterized by spectroscopic techniques.     

Bis(4,4′‐dimethyl‐2,2′‐bipyridine) ruthenium (II) Complexes Containing 2‐Arylimidazo‐ [4,5‐f] [1,10] phenanthroline: Syntheses,Characterization and Third‐order Nonlinear Optical Properties

Four novel mononuclear ruthenium(II) complexes [Ru(dmb)₂L]²⁺ [dmb = 4,4′‐dimethyl‐2,2′‐bipyridine, L = imidazo‐[4,5‐f][1,10]phenanthroline (IP), 2‐phenylimidazo‐[4,5‐f][1,10]phenanthroline (PIP), 2‐(4′‐hydroxyphenyl)imidazo‐[4,5‐f] [1,10] phenanthroline (HOP), 2‐(4′‐dimethylaminophenyl) imidazo‐[4, 5‐f] [1,10] phenanthroline (DMNP)] were synthesized and characterized by ES‐MS, ¹H NMR, UV‐vis and electrochemistry. The nonlinear optical properties of the ruthenium(II) complexes were investigated by Z‐scan techniques with 12 ns laser pulse at 540 nm, and all of them exhibit both nonlinear optical (NLO) absorption and self‐defocusing effect. The corresponding effective NLO susceptibility |x³| of the complexes is in the range of 2.68 × 10^?12‐4.57 × 10^?12 esu.     

Hetero‐ and homo‐leptic Ru(II) catalyzed synthesis of cyclic carbonates from CO2; Synthesis,spectroscopic characterization and electrochemical properties

Based on the a ligand BDPPZ [(9a,13a‐dihydro‐4,5,9,14‐tetraaza‐benzo[b]triphenylene‐11‐yl)‐phenyl‐methanone] (1) and its polypyridyl hetero‐ and homoleptic Ru(II) metal complexes, [Ru(bpy)₂L](PF₆)₂ (2), [Ru(phen)₂L](PF₆)₂ (3), [Ru(dafo)₂L](PF₆)₂ (4), [Ru(dcbpy)₂L](PF₆)₂ (5) and [RuL₃](PF₆)₂ (6) (where, L = ligand, bpy = 2,2′‐bipyridine, phen = 1,10‐phenantroline, dafo = 4,5‐diazafluoren‐9‐one and dcbpy = 3,3′‐dicarboxy‐2,2′‐bipyridine), have been synthesized and characterized by elemental analysis, UV–vis, FT‐IR, ¹H and ¹³C‐NMR spectra (for ligand), molar conductivity measurements and X‐ray powder techniques. The electrochemical parameters of the substituted ligand and its polypyridyl hetero‐ and homoleptic Ru(II) metal complexes are reported by cyclic voltammetry. UV–vis spectroscopy is used to compare the differences between the conjugated π systems in this ligand and its Ru(II) metal complexes. The polypyridyl hetero‐ and homoleptic Ru(II) metal complexes also tested as catalysts for the formation of cyclic organic carbonates from carbon dioxide and liquid epoxides which served as both reactant and solvent. The results showed that the [Ru(L)₃](PF₆)₂ (6) complex is more efficient than the other Ru(II) complexes for the formation of cyclic organic carbonates from carbon dioxide. Copyright © 2010 John Wiley & Sons, Ltd.     

d‐ Versus l‐Glucose Conjugation: Mitochondrial Targeting of a Light‐Activated Dual‐Mode‐of‐Action Ruthenium‐Based Anticancer Prodrug

Light‐activated ruthenium polypyridyl anticancer prodrugs often suffer from poor water solubility, poor selectivity, and/or ill‐defined intracellular targets. Coordination of the d ‐ or l ‐glucose thioether ligand 3 (2‐(2‐(2‐(methylthio)ethoxy)ethoxy)ethyl‐β‐glucopyranoside) to the highly lipophilic ruthenium complex [Ru(tpy)(dppn)(H₂O)]²⁺ ([ 1 ]²⁺; dppn=benzo[i]dipyrido‐[3,2‐a:2′,3′‐c]phenazine, tpy=2,2′:6′,2′′‐terpyridine) solved all these problems at once. The two enantiomers of [Ru(tpy)(dppn)( 3) ][PF₆]₂, [d ‐ 2 ][PF₆]₂ and [l ‐ 2 ][PF₆]₂, were soluble in water, which allowed the influence of the chirality of the glucose moiety on uptake, toxicity, and intracellular localization of the prodrug to be probed without changing any other physicochemical properties. Both compounds showed mild, but different, cytotoxicity in A549 (human lung carcinoma) and MCF‐7 (human breast adenocarcinoma) cancer cells in the dark, whereas following low doses of visible light irradiation (3.1 J cm^?2 at λ = 454 nm), a similar, but high cytotoxicity (EC₅₀ < 1 μm ), was observed. Irrespective of the chirality, both slightly emissive Ru complexes were found in the mitochondria, and two modes of action may contribute to light‐induced cell death: 1) the glucose thioether ligand is photosubstituted by water, thus [ 1 ]²⁺, which interacts with DNA at an exceptionally high 400:1 base pair/Ru ratio, is released; 2) both [ 1 ]²⁺ and [ 2 ]²⁺ produce massive amounts of singlet oxygen, which leads to very efficient photodynamic DNA cleavage.     

Neutral and cationic half‐sandwich arene d6 metal complexes containing pyridyl and pyrimidyl thiourea ligands with interesting bonding modes: Synthesis,structural and anti‐cancer studies

The reaction of [(p‐cymene)RuCl₂]₂ and [Cp*MCl₂]₂ (M = Rh/Ir) with benzoyl (2‐pyrimidyl) thiourea (L1) and benzoyl (4‐picolyl) thiourea (L2) led to the formation of cationic complexes bearing formula [(arene) M (L1)к² _(N,S) Cl]⁺ and [(arene) M (L2)к²_(N,S)Cl]⁺ [(arene) = p‐cymene, M = Ru, ( 1 , 4 ); Cp*, M = Rh ( 2 , 5 ) and Ir ( 3 , 6 )]. Precursor compounds reacted with benzoyl (6‐picolyl) thiourea (L3) affording neutral complexes having formula [(arene) M (L3)к¹_(S)Cl₂] [arene = p‐cymene, M = Ru, ( 7 ); Cp*, M = Rh ( 8 ), Ir ( 9 )]. X‐ray studies revealed that the methyl substituent attached to the pyridine ring in ligands L2 and L3 affects its coordination mode. When methyl group is at the para position of the pyridine ring (L2), the ligand coordinated metal in a bidentate chelating N, S‐ mode whereas methyl group at ortho position (L3), it coordinated in a monodentate mode. Further the anti‐cancer studies of the thiourea derivatives and its complexes carried out against HCT‐116, HT‐29 (human colorectal cancer), Mia‐PaCa‐2 (human pancreatic cancer) and ARPE‐19 (non‐cancer retinal epithelium) cell lines showed that the thiourea ligands are inactive but upon complexation, the metal compounds displayed potent and selective activity against cancer cells in vitro. Iridium complexes were found to be more potent as compared to ruthenium and rhodium complexes.     

Visible‐Light‐Induced Morphological Changes of Giant Vesicles by Photoisomerization of a Ruthenium Aqua Complex

Visible‐ and red‐light responsive vesicles were prepared by incorporating a ruthenium aqua complex having two alkyl chains on tridentate and asymmetrical bidentate ligands (proximal‐ 2 : [Ru(C₁₀tpy)(C₁₀pyqu)OH₂]²⁺, C₁₀tpy=4′‐decyloxy‐2,2′;6′,2“‐terpyridine, C₁₀pyqu=2‐[2′‐(6′‐decyloxy)‐pyridyl]quinoline). The ruthenium complex of proximal‐ 2 with closed alkyl chain geometry and a cylinder‐like molecular shape exhibited photoisomerization to distal‐ 2 with an open alkyl chain geometry and a cone‐like shape, both in an aqueous solution and in vesicle dispersions. We observed that light irradiation of giant vesicles containing proximal‐ 2 induced diverse morphological changes.     

Ruthenium(II/III)‐Based Compounds with Encouraging Antiproliferative Activity against Non‐small‐Cell Lung Cancer

Hereby we present the synthesis of several ruthenium(II) and ruthenium(III) dithiocarbamato complexes. Proceeding from the Na[trans‐Ru^III(dmso)₂Cl₄] ( 2 ) and cis‐[Ru^II(dmso)₄Cl₂] ( 3 ) precursors, the diamagnetic, mixed‐ligand [Ru^IIL₂(dmso)₂] complexes 4 and 5 , the paramagnetic, neutral [Ru^IIIL₃] monomers 6 and 7 , the antiferromagnetically coupled ionic α‐[Ru^III₂L₅]Cl complexes 8 and 9 as well as the β‐[Ru^III₂L₅]Cl dinuclear species 10 and 11 (L=dimethyl‐ (DMDT) and pyrrolidinedithiocarbamate (PDT)) were obtained. All the compounds were fully characterised by elemental analysis as well as ¹H NMR and FTIR spectroscopy. Moreover, for the first time the crystal structures of the dinuclear β‐[Ru^III₂(dmdt)₅]BF₄ ? CHCl₃ ? CH₃CN and of the novel [Ru^IIL₂(dmso)₂] complexes were also determined and discussed. For both the mono‐ and dinuclear Ru^II and Ru^III complexes the central metal atoms assume a distorted octahedral geometry. Furthermore, in vitro cytotoxicity of the complexes has been evaluated on non‐small‐cell lung cancer (NSCLC) NCI‐H1975 cells. All the mono‐ and dinuclear Ru^III dithiocarbamato compounds (i.e., complexes 6 – 10 ) show interesting cytotoxic activity, up to one order of magnitude higher with respect to cisplatin. Otherwise, no significant antiproliferative effect for either the precursors 2 and 3 or the Ru^II complexes 4 and 5 has been observed.     

Chloro(η6‐p‐cymene)(phosphoramidite)ruthenium(II), a 16‐Electron Fragment Stabilized by an η2‐Aryl–Metal Interaction,and Its Use in Asymmetric Cyclopropanation

Chloride abstraction from the half‐sandwich complexes [RuCl₂(η⁶‐p‐cymene)(P*‐κP)] ( 2a : P* = (S_a,R,R)‐ 1a = (1S_a)‐[1,1′‐binaphthalene]‐2,2′‐diyl bis[(1R)‐1‐phenylethyl)]phosphoramidite; 2b : P* = (S_a,R,R)‐ 1b = (1S_a)‐[1,1′‐binaphthalene]‐2,2′‐diyl bis[(1R)‐(1‐(1‐naphthalen‐1‐yl)ethyl]phosphoramidite) with (Et₃O)[PF₆] or Tl[PF₆] gives the cationic, 18‐electron complexes dichloro(η⁶‐p‐cymene){(1S_a)‐[1,1′‐binaphthalene]‐2,2′‐diyl {(1R)‐1‐[(1,2‐η)‐phenyl]ethyl}[(1R)‐1‐phenylethyl]phosphoramidite‐κP}ruthenium(II) hexafluorophosphate ( 3a ) and [Ru(S)]‐dichloro(η⁶‐p‐cymene){(1S_a)‐[1,1′‐binaphthalene]‐2,2′‐diyl {(1R)‐1‐[(1,2‐η)‐naphthalen‐1‐yl]ethyl}[(1R)‐1‐(naphthalen‐1‐yl)ethyl]phosphoramidite‐κP)ruthenium(II) hexafluorophosphate ( 3b ), which feature the η²‐coordination of one aryl substituent of the phosphoramidite ligand, as indicated by ¹H‐, ¹³C‐, and ³¹P‐NMR spectroscopy and confirmed by an X‐ray study of 3b . Additionally, the dissociation of p‐cymene from 2a and 3a gives dichloro{(1S_a)‐[1,1′‐binaphthalene]‐2,2′‐diyl [(1R)‐(1‐(η⁶‐phenyl)ethyl][(1R)‐1‐phenylethyl]phosphoramidite‐κP)ruthenium(II) ( 4a ) and di‐μ‐chlorobis{(1S_a)‐[1,1′‐binaphthalene]‐2,2′‐diyl [(1R)‐1‐(η⁶‐phenyl)ethyl][(1R)‐1‐phenylethyl]phosphoramidite‐κP}diruthenium(II) bis(hexafluorophosphate) ( 5a ), respectively, in which one phenyl group of the N‐substituents is η⁶‐coordinated to the Ru‐center. Complexes 3a and 3b catalyze the asymmetric cyclopropanation of α‐methylstyrene with ethyl diazoacetate with up to 86 and 87% ee for the cis‐ and the trans‐isomers, respectively.     

Heterodinuclear Ruthenium(II) Complexes of the Bridging Ligand 1,6,7,12‐Tetraazaperylene with Iron(II), Cobalt(II), Nickel(II), as well as Palladium(II) and Platinum(II)

The first heterodinuclear ruthenium(II) complexes of the 1,6,7,12‐tetraazaperylene (tape) bridging ligand with iron(II), cobalt(II), and nickel(II) were synthesized and characterized. The metal coordination sphere in this complexes is filled by the tetradentate N,N′‐dimethyl‐2,11‐diaza[3.3](2,6)‐pyridinophane (L‐N₄Me₂) ligand, yielding complexes of the general formula [(L‐N₄Me₂)Ru(µ‐tape)M(L‐N₄Me₂)](ClO₄)₂(PF₆)₂ with M = Fe {[ 2 ](ClO₄)₂(PF₆)₂}, Co {[ 3 ](ClO₄)₂(PF₆)₂}, and Ni {[ 4 ](ClO₄)₂(PF₆)₂}. Furthermore, the heterodinuclear tape ruthenium(II) complexes with palladium(II)‐ and platinum(II)‐dichloride [(bpy)₂Ru(μ‐tape)PdCl₂](PF₆)₂ {[ 5 ](PF₆)₂} and [(dmbpy)₂Ru(μ‐tape)PtCl₂](PF₆)₂ {[ 6 ](PF₆)₂}, respectively were also prepared. The molecular structures of the complex cations [ 2 ]⁴⁺ and [ 4 ]⁴⁺ were discussed on the basis of the X‐ray structures of [ 2 ](ClO₄)₄ · MeCN and [ 4 ](ClO₄)₄ · MeCN. The electrochemical behavior and the UV/Vis absorption spectra of the heterodinuclear tape ruthenium(II) complexes were explored and compared with the data of the analogous mono‐ and homodinuclear ruthenium(II) complexes of the tape bridging ligand.     

Proton‐Induced Generation of Remote N‐Heterocyclic Carbene–Ru Complexes

The proton‐induced Ru?C bond variation, which was previously found to be relevant in the water oxidation, has been investigated by using cyclometalated ruthenium complexes with three phenanthroline (phen) isomers. The designed complexes, [Ru(bpy)₂(1,5‐phen)]⁺ ([ 2 ]⁺), [Ru(bpy)₂(1,6‐phen)]⁺ ([ 3 ]⁺), and [Ru(bpy)₂(1,7‐phen)]⁺ ([ 4 ]⁺) were newly synthesized and their structural and electronic properties were analyzed by various spectroscopy and theoretical protocols. Protonation of [ 4 ]⁺ triggered profound electronic structural change to form remote N‐heterocyclic carbene (rNHC), whereas protonation of [ 2 ]⁺ and [ 3 ]⁺ did not affect their structures. It was found that changes in the electronic structure of phen beyond classical resonance forms control the rNHC behavior. The present study provides new insights into the ligand design of related ruthenium catalysts.     

Strain‐Induced Double Carbon–Carbon Bond Activations of Cycloparaphenylenes by a Platinum Complex: Application to the Synthesis of Cyclic Diketones

The carbon–carbon (C?C) bond activation of [n]cycloparaphenylenes ([n]CPPs) by a transition‐metal complex is herein reported. The Pt⁰ complex Pt(PPh₃)₄ regioselectively cleaves two C?C σ bonds of [5] CPP and [6]CPP to give cyclic dinuclear platinum complexes in high yields. Theoretical calculations reveal that the relief of ring strain drives the reaction. The cyclic complex was further transformed into a cyclic diketone by using a CO insertion reaction.     

Synthesis and characterization of new complexes of the type [Ru(CO)2Cl2 (2‐phenyl‐1,8‐naphthyridine‐kN) (2‐phenyl‐1,8‐naphthyridine‐kN′)]. Preliminary applications in homogeneous catalysis

Novel ruthenium (II) complexes were prepared containing 2‐phenyl‐1,8‐naphthyridine derivatives. The coordination modes of these ligands were modified by addition of coordinating solvents such as water into the ethanolic reaction media. Under these conditions 1,8‐naphthyridine (napy) moieties act as monodentade ligands forming unusual [Ru(CO)₂Cl₂(η¹‐2‐phenyl‐1,8‐naphthyridine‐ kN )(η¹‐2‐phenyl‐1,8‐naphthyridine‐kN′)] complexes. The reaction was reproducible when different 2‐phenyl‐1,8‐naphthyridine derivatives were used. On the other hand, when dry ethanol was used as the solvent we obtained complexes with napy moieties acting as a chelating ligand. The structures proposed for these complexes were supported by NMR spectra, and the presence of two ligands in the [Ru(CO)₂Cl₂(η¹‐2‐phenyl‐1,8‐naphthyridine‐ kN )(η¹‐2‐phenyl‐1,8‐naphthyridine‐kN′)] type complexes was confirmed using elemental analysis. All complexes were tested as catalysts in the hydroformylation of styrene showing moderate activity in N,N′‐dimethylformamide. Copyright © 2008 John Wiley & Sons, Ltd.     

Synthesis,structural and chemosensitivity studies of arene d6 metal complexes having N‐phenyl‐N´‐(pyridyl/pyrimidyl)thiourea derivatives

The d⁶ metal complexes of thiourea derivatives were synthesized to investigate its cytotoxicity. Treatment of various N‐phenyl‐N´ pyridyl/pyrimidyl thiourea ligands with half‐sandwich d⁶ metal precursors yielded a series of cationic complexes. Reactions of ligand (L1‐L3) with [(p‐cymene)RuCl₂]₂ and [Cp*MCl₂]₂ (M = Rh/Ir) led to the formation of a series of cationic complexes bearing general formula [(arene)M(L1)к²_(N,S)Cl]⁺, [(arene)M(L2)к²_(N,S)Cl]⁺ and [(arene)M(L3)к²_(N,S)Cl]⁺ [arene = p‐cymene, M = Ru ( 1 , 4 , 7 ); Cp*, M = Rh ( 2 , 5 , 8 ); Cp*, Ir ( 3 , 6 , 9 )]. These compounds were isolated as their chloride salts. X‐ray crystallographic studies of the complexes revealed the coordination of the ligands to the metal in a bidentate chelating N,S‐ manner. Further the cytotoxicity studies of the thiourea derivatives and its complexes evaluated against HCT‐116 (human colorectal cancer), MIA‐PaCa‐2 (human pancreatic cancer) and ARPE‐19 (non‐cancer retinal epithelium) cancer cell lines showed that the thiourea ligands displayed no activity. Upon complexation however, the metal compounds possesses cytotoxicity and whilst potency is less than cisplatin, several complexes exhibited greater selectivity for HCT‐116 or MIA‐PaCa‐2 cells compared to ARPE‐19 cells than cisplatin in vitro. Rhodium complexes of thiourea derivatives were found to be more potent as compared to ruthenium and iridium complexes.     

Chiral Bis(oxazoline) Ruthenium Complexes with Bipyridyl‐Type N‐Heteroaromatics: Comparative Stereochemical and Photochemical Characterization of their Λ‐ and Δ‐Diastereomeric Geminate Isomers

Diastereomeric geminate pairs of chiral bis(2‐oxazoline) ruthenium complexes with bipyridyl‐type N‐heteroaromatics, Λ‐ and Δ‐[Ru(L‐ L)₂(iPr‐biox)]²⁺ (iPr‐biox=(4S,4′S)‐4,4′‐diisopropyl‐2,2′‐bis(2‐oxazoline); L‐ L=2,2′‐bipyridyl (bpy) for 1 Λ and 1 Δ, 4,4′‐dimethyl‐2,2′‐bipyridyl (dmbpy) for 2 Λ and 2 Δ, and 1,10‐phenanthroline (phen) for 3 Λ and 3 Δ), were separated as BF₄ and PF₆ salts and were subjected to the comparative studies of their stereochemical and photochemical characterization. DFT calculations of 1 Λ and 1 Δ electronic configurations for the lowest triplet excited state revealed that their MO‐149 (HOMO) and MO‐150 (lower SOMO) characters are interchanged between them and that the phosphorescence‐emissive states are an admixture of a Ru‐to‐biox charge‐transfer state and an intraligand excited state within the iPr‐biox. Furthermore, photoluminescence properties of the two Λ,Δ‐diastereomeric series are discussed with reference to [Ru(bpy)₃]²⁺.     

π‐Ruthenium Complexes of Hexaphyrins(1.1.1.1.1.1): A Triple‐Decker Complex Bearing Two Ruthenoarene Units

Ruthenium(II) π‐coordination onto [28]hexaphyrins(1.1.1.1.1.1) has been accomplished. Reactions of bis‐Au^III and mono‐Au^III complexes of hexakis(pentafluorophenyl) [28]hexaphyrin with [RuCl₂(p‐cymene)]₂ in the presence of NaOAc gave the corresponding π‐ruthenium complexes, in which the [(p‐cymene)Ru]^II fragment sat on the deprotonated side pyrrole. A similar reaction of the bis‐Pd^II [26]hexaphyrin complex afforded a triple‐decker complex, in which the two [(p‐cymene)Ru]^II fragments sat on both sides of the center of the [26]hexaphyrin framework.     

Four‐Center Oxidation State Combinations and Near‐Infrared Absorption in [Ru(pap)(Q)2]n (Q=3,5‐Di‐tert‐butyl‐N‐aryl‐1,2‐benzoquinonemonoimine,pap=2‐Phenylazopyridine)

The complex series [Ru(pap)(Q)₂]ⁿ ([ 1 ]ⁿ–[ 4 ]ⁿ; n=+2, +1, 0, ?1, ?2) contains four redox non‐innocent entities: one ruthenium ion, 2‐phenylazopyridine (pap), and two o‐iminoquinone moieties, Q=3,5‐di‐tert‐butyl‐N‐aryl‐1,2‐benzoquinonemonoimine (aryl=C₆H₅ ( 1⁺ ); m‐(Cl)₂C₆H₃ ( 2⁺ ); m‐(OCH₃)₂C₆H₃ ( 3⁺ ); m‐(tBu)₂C₆H₃ ( 4 ⁺)). A crystal structure determination of the representative compound, [ 1 ]ClO₄, established the crystallization of the ctt‐isomeric form, that is, cis and trans with respect to the mutual orientations of O and N donors of two Q ligands, and the coordinating azo N atom trans to the O donor of Q. The sensitive C? O (average: 1.299(3) Å), C? N (average: 1.346(4) Å) and intra‐ring C? C (meta; average: 1.373(4) Å) bond lengths of the coordinated iminoquinone moieties in corroboration with the N?N length (1.292(3) Å) of pap in 1 ⁺ establish [Ru^III(pap⁰)(Q^.?)₂]⁺ as the most appropriate electronic structural form. The coupling of three spins from one low‐spin ruthenium(III) (t_2g⁵) and two Q^.? radicals in 1 ⁺– 4 ⁺ gives a ground state with one unpaired electron on Q^.?, as evident from g=1.995 radical‐type EPR signals for 1 ⁺– 4 ⁺. Accordingly, the DFT‐calculated Mulliken spin densities of 1 ⁺ (1.152 for two Q, Ru: ?0.179, pap: 0.031) confirm Q‐based spin. Complex ions 1 ⁺– 4 ⁺ exhibit two near‐IR absorption bands at about λ=2000 and 920 nm in addition to intense multiple transitions covering the visible to UV regions; compounds [ 1 ]ClO₄–[ 4 ]ClO₄ undergo one oxidation and three separate reduction processes within ±2.0 V versus SCE. The crystal structure of the neutral (one‐electron reduced) state ( 2 ) was determined to show metal‐based reduction and an EPR signal at g=1.996. The electronic transitions of the complexes 1 ⁿ– 4 ⁿ (n=+2, +1, 0, ?1, ?2) in the UV, visible, and NIR regions, as determined by using spectroelectrochemistry, have been analyzed by TD‐DFT calculations and reveal significant low‐energy absorbance (λ_max>1000 nm) for cations, anions, and neutral forms. The experimental studies in combination with DFT calculations suggest the dominant valence configurations of 1 ⁿ– 4 ⁿ in the accessible redox states to be [Ru^III(pap⁰)(Q^.?)(Q⁰)]²⁺ ( 1 ²⁺– 4 ²⁺)→[Ru^III(pap⁰)(Q^.?)₂]⁺ ( 1 ⁺– 4 ⁺)→[Ru^II(pap⁰)(Q^.?)₂] ( 1 – 4 )→[Ru^II(pap^.?)(Q^.?)₂]^? ( 1 ^?– 4 ^?)→[Ru^III(pap^.?)(Q^2?)₂]^2? ( 1 ^2?– 4 ^2?).     

Transfer hydrogenation of ketones catalysed by half‐sandwich (η6‐p‐cymene) ruthenium(II) complexes incorporating benzoylhydrazone ligands

Neutral half‐sandwich η⁶‐p ‐cymene ruthenium(II) complexes of general formula [Ru(η⁶‐p ‐cymene)Cl(L)] (HL = monobasic O, N bidendate benzoylhydrazone ligand) have been synthesized from the reaction of [Ru(η⁶‐p ‐cymene)(μ‐Cl)Cl]₂ with acetophenone benzoylhydrazone ligands. All the complexes have been characterized using analytical and spectroscopic (Fourier transform infrared, UV–visible, ¹H NMR, ¹³C NMR) techniques. The molecular structures of three of the complexes have been determined using single‐crystal X‐ray diffraction, indicating a pseudo‐octahedral geometry around the ruthenium(II) ion. All the ruthenium(II) arene complexes were explored as catalysts for transfer hydrogenation of a wide range of aromatic, cyclic and aliphatic ketones with 2‐propanol using 0.1 mol% catalyst loading, and conversions of up to 100% were obtained. Further, the influence of other variables on the transfer hydrogenation reaction, such as base, temperature, catalyst loading and substrate scope, was also investigated.     

The Ruthenostannylene Complex [Cp*(IXy)H2Ru‐Sn‐Trip]: Providing Access to Unusual Ru‐Sn Bonded Stanna‐imine,Stannene, and Ketenylstannyl Complexes

Reactivity studies of the thermally stable ruthenostannylene complex [Cp*(IXy)(H)₂Ru Sn Trip] ( 1 ; IXy=1,3‐bis(2,6‐dimethylphenyl)imidazol‐2‐ylidene; Cp*=η⁵‐C₅Me₅; Trip=2,4,6‐iPr₃C₆H₂) with a variety of organic substrates are described. Complex 1 reacts with benzoin and an α,β‐unsaturated ketone to undergo [1+4] cycloaddition reactions and afford [Cp*(IXy)(H)₂RuSn(κ²‐O,O‐OCPhCPhO)Trip] ( 2 ) and [Cp*(IXy)(H)₂RuSn(κ²‐O,C‐OCPhCHCHPh)Trip] ( 3 ), respectively. The reaction of 1 with ethyl diazoacetate resulted in a tin‐substituted ketene complex [Cp*(IXy)(H)₂RuSn(OC₂H₅)(CHCO)Trip] ( 4 ), which is most likely a decomposition product from the putative ruthenium‐substituted stannene complex. The isolation of a ruthenium‐substituted stannene [Cp*(IXy)(H)₂RuSn(Flu)Trip] ( 5 ) and stanna‐imine [Cp*(IXy)(H)₂RuSn(κ²‐N,O‐NSO₂C₆H₄Me)Trip] ( 6 ) complexes was achieved by treatment of 1 with 9‐diazofluorene and tosyl azide, respectively.